← All diseases Brain and nervous system

Multiple sclerosis (progressive)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchEvidence of the highest level only (104)Meta-analysis (24)Treatment guideline (1)Randomized trial (43)Systematic review (21)Phase 3 Study (15)Clinical trial (370)Review article (234)Early study (phase 1 or 2) (22)Case report (83)Laboratory or animal study (21)Commentary or editorial (19) Studies currently recruiting participants only (33)

Filter

Publications (1203)

• Functional Components of Cognitive Impairment in Multiple Sclerosis: A Cross-Sectional Investigation. (2017/11/28) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Endogenous Opioids in the Etiology and Treatment of Multiple Sclerosis. (2017/11/27) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Experimental In Vivo Models of Multiple Sclerosis: State of the Art. (2017/11/27) ♡
• Evaluation of neurological changes in secondary progressive multiple sclerosis patients treated with immune modulator MIS416: results from a feasibility study. (2017/11/16) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Congenital myopathies: clinical phenotypes and new diagnostic tools. (2017/11/15) ♡
• Inhibition of Retrograde Transport Limits Polyomavirus Infection In Vivo. (2017/11/15) ♡
• Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis. (2017/11/15) ♡
• Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments. (2017/11/10) ♡
• Fingolimod-associated PML with mild IRIS in MS: A clinicopathologic study. (2017/11/10) ♡
• Limbic system damage in MS: MRI assessment and correlations with clinical testing. (2017/11/09) ♡
• Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals. (2017/11/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of Immunological Memory Cells as a Therapeutic Target in Multiple Sclerosis. (2017/11/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date. (2017/11/02) ♡
• Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis. (2017/11/01) ♡
• Interleukin 1 receptor antagonist and 2'-5'-oligoadenylate synthetase-like molecules as novel biomarkers for multiple sclerosis patients in Bahrain. (2017/11/01) ♡
• High dose biotin as treatment for progressive multiple sclerosis. (2017/11/01) ♡
• Elevated plasma fibrinogen levels in multiple sclerosis patients during relapse. (2017/11/01) ♡
• The neutrophil-to-lymphocyte ratio as disease activity marker in multiple sclerosis and optic neuritis. (2017/11/01) ♡
• Epidemiological and clinical characteristics of multiple sclerosis in paediatric population in Slovenia: A descriptive nation-wide study. (2017/11/01) ♡
• Personalized medicine in multiple sclerosis. (2017/11/01) ♡
• Biomarkers in the evolution of multiple sclerosis. (2017/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Facial emotion recognition, theory of mind and empathy in multiple sclerosis]. (2017/11/01) ♡
• Common clinical features of pediatric multiple sclerosis in Pakistan - A report of 15 cases. (2017/11/01) ♡
• The Effect of Emotional Intelligence Training on Self-efficacy in Women with Multiple Sclerosis. (2017/11/01) ♡
• Access to and Use of Clinical Services and Disease-Modifying Therapies by People with Progressive Multiple Sclerosis in the United Kingdom. (2017/11/01) ♡
• Prevention and therapy of JC polyomavirus-mediated progressive multifocal leukoencephalopathy - a realistic possibility? (2017/10/31) ♡
• Quality of life and social support in patients with multiple sclerosis. (2017/10/29) ♡
• Suppression of Inflammatory Demyelinaton and Axon Degeneration through Inhibiting Kv3 Channels. (2017/10/26) ♡
• MerTK-mediated regulation of myelin phagocytosis by macrophages generated from patients with MS. (2017/10/16) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular mechanisms of omega-3 fatty acids in the migraine headache. (2017/10/07) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Multimodal exercise training in multiple sclerosis: A randomized controlled trial in persons with substantial mobility disability. (2017/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current concepts in multiple sclerosis therapy. (2017/09/28) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Stem cells therapy: the future in the management of systemic sclerosis? A case report. (2017/09/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Secondary aneurysmal bone cyst in McCune-Albright syndrome. (2017/09/01) ♡
• Enrichment of Retroviral Sequences in Brain Tissue from Patients with Severe Demyelinating Diseases. (2017/08/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Caspases in retinal ganglion cell death and axon regeneration. (2017/07/03) ♡
• Effects of a multimodal intervention on gait and balance of subjects with progressive multiple sclerosis: a prospective longitudinal pilot study. (2017/06/26) ♡
• [Experience with natalizumab-treatment at Semmelweis University]. (2017/05/30) ♡
• Mitochondrial dysfunctions in 7-ketocholesterol-treated 158N oligodendrocytes without or with α-tocopherol: Impacts on the cellular profil of tricarboxylic cycle-associated organic acids, long chain saturated and unsaturated fatty acids, oxysterols, cholesterol and cholesterol precursors. (2017/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Vitamin D and multiple sclerosis: An update. (2017/05/01) ♡
• [Risk factors analysis for low back pain in patients with multiple sclerosis]. (2017/04/25) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. WITHDRAWN: Interventions for fatigue and weight loss in adults with advanced progressive illness. (2017/04/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in the treatment of relapsing-remitting multiple sclerosis: the role of pegylated interferon β-1a. (2017/03/24) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Multimodal, Nonpharmacologic Intervention Improves Mood and Cognitive Function in People with Multiple Sclerosis. (2017/03/01) ♡
• Access, delivery and perceived efficacy of physiotherapy and use of complementary and alternative therapies by people with progressive multiple sclerosis in the United Kingdom: An online survey. (2017/02/01) ♡
• Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study. (2017/01/04) ♡
• Effect of Roux-en-Y gastric bypass and diet-induced weight loss on diabetic kidney disease in the Zucker diabetic fatty rat. (2017/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. What is "Hyper" in the ALS Hypermetabolism? (2017/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Rare Neurodegenerative Diseases: Clinical and Genetic Update. (2017/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Dimethyl fumarate (tecfidera) is the first line treatment choice in patients with remitting multiple sclerosis]. (2017/01/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.